Medicus Pharma Ltd.

MDCX·NasdaqCM·Healthcare
Compare
1.8800−0.1500 (−7.39%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
After hours1.8500−0.0300 (−1.60%)Nov 4, 7:00 PM EST

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.0300
Open2.1200
Day range1.71002.1560
52-week range1.7100127.5000
Off day high−12.80%
Off 52-week high−98.53%
Volume233.97K
Avg. volume (3M)107.32K
Market cap3.57M
EPS (TTM)-119.00
Forward P/E-0.08
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.15
Shares outstanding1.90M
Short interest3.17% of float
Earnings date—
Analyst target203.7500
Profit margin0.00%

Against its peers

Compare in full ›
MDCX JNJ BIIB JNJ.NE SNGX PMCB
Market cap 3.57M 665.19B 37.61B 915.54B 7.64M 4.09M
P/E (TTM) — 41.9 110.2 25.4 — —
Forward P/E -0.1 23.8 15.6 — -1.4 -1.0
Price/book -1.3 8.2 2.0 0.8 1.1 0.1
Dividend yield — 1.94% — 2.49% — —
1-year change −98.23% +43.10% +62.24% +40.84% −73.91% −61.58%
Today −7.39% +3.81% +2.22% +4.32% −1.49% +12.03%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All MDCX news ›
Seeking Alpha·Positive

Medicus Pharma jumps as SkinJect explores $135M SPAC deal

Medicus Pharma’s SkinJect signed an LOI with a SPAC on a $135M deal to fund its Gorlin syndrome study and NDA prep. MDV Edwards/iStock Editorial via Getty Images - Medicus Pharma (MDCX) announced Wednesday that its wholly owned subsidiary,…

From the 4Search news index, newest first.

In the news

22mentions in 30 days
19with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance